Description
LZCapTM AG(3'Ma-Biotin) is a Cap 1 analog with a Biotin label, which can be used as the capping agent for producing mRNAs in an “one-pot” process. Through T7 polymerase, mRNA with 5' end Cap 1 structure was generated by co-transcription using LZCapTM AG(3'Ma-Biotin), NTPs, and template DNA. The capped mRNA could be directly translated and expressed in cells and in vivo. mRNA capped with LZCapTM AG(3'Ma-Biotin) can be bound to streptavidin magnetic beads for biological functional exploration. Moreover, Biotin, as a common molecule in the body, is involved in various intracellular biological functions and exhibits strong binding affinity with many proteins. Biotin-labeled mRNA holds potential for exploration in biology.
Specifications
|
Cat.No. |
10691ES10 / 10691ES60 |
|
Size |
50 μL / 100 μL |
|
Molecular Formula |
C43H60N18O25P4S（Free acid） |
|
Molecular Weight |
1385.01（Free acid） |
|
Concentration |
25 mM |
|
Purity |
HPLC ≥90% |
|
Salt type |
NH4+ |
|
Structure |
|
Components
|
Name |
10691ES10 |
10691ES60 |
|
LZCapTM AG(3'Ma-Biotin) |
50 μL |
100 μL |
Shipping and Storage
This product should be stored at -25--15℃ for 12 months.
Documents:
Safety Data Sheet
Manuals
10691_Manual_Ver.EN20250716.pdf
Payment & Security
Your payment information is processed securely. We do not store credit card details nor have access to your credit card information.
Inquiry
You may also like
FAQ
The product is for research purposes only and is not intended for therapeutic or diagnostic use in humans or animals. Products and content are protected by patents, trademarks, and copyrights owned by Yeasen Biotechnology. Trademark symbols indicate the country of origin, not necessarily registration in all regions.
Certain applications may require additional third-party intellectual property rights.
Yeasen is dedicated to ethical science, believing our research should address critical questions while ensuring safety and ethical standards.